Oncology
2 drugs are in development for Bile Duct Cancer.
- Companies
- 2
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Bile Duct Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1/Phase 2(2)
| Drug | Company |
|---|---|
| certepetide | LISATA THERAPEUTICS, INC. (LSTA) |
| eli-002 2p | Elicio Therapeutics, Inc. (ELTX) |
About this indication
Bile Duct Cancer context
Oncology·MeSH: Bile Duct Neoplasms (D001650)
Frequently asked questions
How many drugs are in development for Bile Duct Cancer?
BioSniper tracks 2 drugs in development for Bile Duct Cancer across 2 companies.
How many clinical trials target Bile Duct Cancer?
There are 5 clinical trials targeting Bile Duct Cancer tracked by BioSniper.